Health Watch Home
Health Care Value
Transparency Costs
Transparency Quallity
Health Care Competition
Freedom of Information
  Report an Incident
  Join Health Watch
 Search Health Watch
Subscribe to Health Watch USA's Newsletter

To contact Health Watch USA please  use the following E-Mail Address

Content in this website may be linked to, as long as the linking webpage and passage has a known and clearly stated author.


New and Stronger Emphasis on COVID-19 Non-Pharmaceutical Strategies to Reduce Spread

View OpEd:  

1. Kurhade C. Zou J. Xia H. et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster. Nature Medicine. Nov. 30, 2022.
2. Buonanno G, Ricolfi L, Morawska L, Stabile L. Increasing ventilation reduces SARS-CoV-2 airborne transmission in schools: A retrospective cohort study in Italy's Marche region. Frontiers in Public Health. Dec. 9, 2022.
3. SARS-CoV-2 on food surfaces: Lay Summary. United Kingdom Foods and Standards Agency. Nov. 29, 2022.
4. Qi L, Tang W, Wang J, et al. Outbreak Reports: An Outbreak of SARS-CoV-2 Omicron Subvariant BA.2.76 in an Outdoor Park — Chongqing Municipality, China, August 2022. China CDC Weekly. 2022, 4(46): 1039-1042
5. Prather E. BQ.1.1 is among the most immune-evasive COVID variants yet. It’s coming in hot in the U.S. Fortune Well. Oct. 15, 2022.
6. Yirka B. Omicron variant BQ.1.1 found to be resistant to all monoclonal antibody treatments. Medical Xpress. Nov. 22, 2022.
7. COVID Data Tracker. CDC. Accessed Dec. 12, 2022. href="">
8. Rec8. Recht H. Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits. KHN. Dec. 7, 2022.
9. Daley J, Zialcita P. How to think like an aerosol scientist this holiday season to stay healthy. CPR News. Nov. 16, 2022.

All information contained on this website is the express opinion of Health Watch USA. lth Watch USA, inc. is a non-profit 501C3 organization based in Kentuckypan>